Polygenic Contributions to Lithium Augmentation Outcomes in Unipolar Depression

Are polygenic risk scores (PRS) for major psychiatric disorders associated with favorable treatment outcomes after lithium augmentation (LA) in major depression?In this cohort study with 193 patients with major depressive disorder (MDD) who did not respond to antidepressants, the PRS for bipolar disorder (BIP) was significantly associated with response and remission after at least 4 weeks of LA. Additionally, we found an association between the MDD-PRS and LA response.Individuals with a higher polygenic burden for BIP and lower polygenic burden for MDD are more likely to experience favorable treatment outcomes following LA, offering new opportunities for personalized medicine approaches.

Corresponding Author: Julia Kraft, MSc, Department of Psychiatry and Psychotherapy, Charité – Universitätsmedizin Berlin, Campus Charité Mitte, Charitéplatz 1, 10117 Berlin, Germany (julia.kraft@charite.de).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.